Nelfinavir-d3

更新时间:2024-07-17 13:55:32

Nelfinavir-d3结构式
Nelfinavir-d3结构式
品牌特惠专场
常用名 Nelfinavir-d3 英文名 Nelfinavir-d3
CAS号 1217629-70-3 分子量 567.782
密度 1.2±0.1 g/cm3 沸点 786.8±60.0 °C at 760 mmHg
分子式 C32H45N3O4S 熔点 N/A
MSDS N/A 闪点 429.7±32.9 °C

 Nelfinavir-d3用途


奈非那韦d3(AG1341-d3)是氘标记的奈非那韦。奈非那韦(AG-1341)是一种有效的口服生物利用的HIV-1蛋白酶抑制剂(Ki=2nm),用于治疗HIV感染。奈非那韦是一种广谱抗癌药物[1][2][3]。

 Nelfinavir-d3名称

英文名 Nelfinavir-d3
英文别名 更多

 Nelfinavir-d3生物活性

描述 奈非那韦d3(AG1341-d3)是氘标记的奈非那韦。奈非那韦(AG-1341)是一种有效的口服生物利用的HIV-1蛋白酶抑制剂(Ki=2nm),用于治疗HIV感染。奈非那韦是一种广谱抗癌药物[1][2][3]。
相关类别
体外研究 氢、碳和其他元素的稳定重同位素已被纳入药物分子,主要作为药物开发过程中定量的示踪剂。氘化因其可能影响药物的药代动力学和代谢特征而受到关注[1]。
参考文献

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Mondal D, et al. Nelfinavir suppresses signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones. Ochsner J. 2013 Spring;13(1):76-90.

[3]. Gills JJ, et al. Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that inducesendoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin Cancer Res. 2007 Sep 1;13(17):5183-94.

[4]. Kaldor SW, et al. Nelfinavir mesylate (AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. J Med Chem. 1997 Nov 21;40(24):3979-85.

[5]. Bono C, et al. The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo. Haematologica. 2012;97(7):1101‐1109.

[6]. Qi Sun, et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021 May 29;6(1):212.

 Nelfinavir-d3物理化学性质

密度 1.2±0.1 g/cm3
沸点 786.8±60.0 °C at 760 mmHg
分子式 C32H45N3O4S
分子量 567.782
闪点 429.7±32.9 °C
精确质量 567.313049
LogP 6.98
蒸汽压 0.0±2.9 mmHg at 25°C
折射率 1.619

 Nelfinavir-d3英文别名

(3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide
HO3OGH5D7I
(3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-{(E)-[hydroxy(3-hydroxy-2-methylphenyl)methylene]amino}-4-(phenylsulfanyl)butyl]-N-(2-methyl-2-propanyl)decahydro-3-isoquinolinecarboximidic acid
3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-
Nelfinavir
[3S-[2(2S*,3S*),3a,4ab,8ab]]-N-(1,1-Dimethylethyl)decahydro-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide
[3S-(3R*,4aR*,8aR*,2'S*,3'S*)]-2-[2'-hydroxy-3'-phenylthiomethyl-4'-aza-5'-oxo-5'-(2''-methyl-3''-hydroxyphenyl)pentyl]decahydroisoquinoline-3-N-t-butylcarboxamide
(3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]-N-(2-methyl-2-propanyl)decahydro-3-isoquinolinecarboxamide
3-Isoquinolinecarboximidic acid, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[[(1E)-hydroxy(3-hydroxy-2-methylphenyl)methylene]amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-
MFCD01938163